NO951122D0 - Anvendelse av hyaluronsyre for å forhindre arteriell restenose - Google Patents

Anvendelse av hyaluronsyre for å forhindre arteriell restenose

Info

Publication number: NO951122D0
Authority: NO; Norway
Prior art keywords: hyaluronic acid; arterial restenosis; prevent arterial; prevent; restenosis
Prior art date: 1992-09-25

Application number

NO951122A

Other languages

English (en)

Other versions

NO309457B1 (no

NO951122L (no

Inventor

Rudolf Edgar Falk

Samuel Simon Sculai

Eva Anne Turley

Original Assignee

Norpharmco Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-09-25

Filing date

1995-03-23

Publication date

1995-03-23

1993-09-22 Priority claimed from PCT/CA1993/000388 external-priority patent/WO1994007505A1/en

1995-03-23 Application filed by Norpharmco Inc filed Critical Norpharmco Inc

1995-03-23 Publication of NO951122D0 publication Critical patent/NO951122D0/no

1995-03-23 Publication of NO951122L publication Critical patent/NO951122L/no

2001-02-05 Publication of NO309457B1 publication Critical patent/NO309457B1/no

Links

KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title 1
206010051113 Arterial restenosis Diseases 0.000 title 1
229920002674 hyaluronan Polymers 0.000 title 1
229960003160 hyaluronic acid Drugs 0.000 title 1
230000002265 prevention Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Molecular Biology (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Materials For Medical Uses (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Saccharide Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO951122A 1992-09-25 1995-03-23 Anvendelse av hyaluronsyre i fremstillingen av en farmasöytisk sammensetning for å forhindre arteriell restenose NO309457B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CA002079205A CA2079205C (en)	1992-09-25	1992-09-25	Use of hyaluronic acid and forms to prevent arterial restenosis
PCT/CA1993/000388 WO1994007505A1 (en)	1991-07-03	1993-09-22	Use of hyaluronic acid and forms to prevent arterial restenosis

Publications (3)

Publication Number	Publication Date
NO951122D0 true NO951122D0 (no)	1995-03-23
NO951122L NO951122L (no)	1995-03-23
NO309457B1 NO309457B1 (no)	2001-02-05

Family

ID=4150463

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO951122A NO309457B1 (no)	1992-09-25	1995-03-23	Anvendelse av hyaluronsyre i fremstillingen av en farmasöytisk sammensetning for å forhindre arteriell restenose

Country Status (26)

Country	Link
EP (1)	EP0661981B1 (no)
JP (1)	JP3742955B2 (no)
CN (1)	CN1057908C (no)
AP (1)	AP448A (no)
AT (1)	ATE141054T1 (no)
AU (1)	AU670117B2 (no)
BR (1)	BR9307221A (no)
CA (1)	CA2079205C (no)
CZ (1)	CZ288986B6 (no)
DE (1)	DE69303931T2 (no)
DK (1)	DK0661981T3 (no)
ES (1)	ES2091031T3 (no)
GR (1)	GR3021171T3 (no)
HK (1)	HK35397A (no)
HU (2)	HU227067B1 (no)
IL (1)	IL107087A0 (no)
IN (1)	IN181289B (no)
MD (1)	MD960294A (no)
MX (1)	MX9305887A (no)
NO (1)	NO309457B1 (no)
NZ (1)	NZ255978A (no)
PL (1)	PL308201A1 (no)
SG (1)	SG48845A1 (no)
SK (1)	SK36895A3 (no)
TW (1)	TW271401B (no)
ZA (1)	ZA937068B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5811447A (en)	1993-01-28	1998-09-22	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en)	1991-09-27	2003-02-04	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
US6663881B2 (en)	1993-01-28	2003-12-16	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
US5981568A (en)	1993-01-28	1999-11-09	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en)	1993-05-13	2002-12-10	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
ATE295745T1 (de) *	1997-08-22	2005-06-15	Denki Kagaku Kogyo Kk	Hyaluronsäure-gel, verfahren zur dessen herstellung und hyaluronsäure-gel enthaltendes medizinisches material
FR2813791B1 (fr)	2000-09-14	2004-03-12	Lafon Labor	Utilisation de 2- et 4-quinolones pour inhiber la neo-proliferation intimale
US6613083B2 (en)	2001-05-02	2003-09-02	Eckhard Alt	Stent device and method
FR2994846B1 (fr)	2012-08-29	2014-12-26	Vivacy Lab	Composition, sterilisee, comprenant au moins un acide hyaluronique et de l'ascorbyl phosphate de magnesium

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1340994C (en) *	1989-09-21	2000-05-16	Rudolf Edgar Dr. Falk	Treatment of conditions and disease

1992
- 1992-09-25 CA CA002079205A patent/CA2079205C/en not_active Expired - Lifetime
1993
- 1993-09-22 EP EP93920624A patent/EP0661981B1/en not_active Expired - Lifetime
- 1993-09-22 CZ CZ1995662A patent/CZ288986B6/cs not_active IP Right Cessation
- 1993-09-22 DE DE69303931T patent/DE69303931T2/de not_active Expired - Lifetime
- 1993-09-22 NZ NZ255978A patent/NZ255978A/en not_active IP Right Cessation
- 1993-09-22 AU AU48126/93A patent/AU670117B2/en not_active Expired
- 1993-09-22 HU HU9500857A patent/HU227067B1/hu unknown
- 1993-09-22 ES ES93920624T patent/ES2091031T3/es not_active Expired - Lifetime
- 1993-09-22 AP APAP/P/1993/000568A patent/AP448A/en active
- 1993-09-22 BR BR9307221A patent/BR9307221A/pt not_active Application Discontinuation
- 1993-09-22 PL PL93308201A patent/PL308201A1/xx unknown
- 1993-09-22 JP JP50854394A patent/JP3742955B2/ja not_active Expired - Lifetime
- 1993-09-22 TW TW082107796A patent/TW271401B/zh active
- 1993-09-22 SG SG1996002824A patent/SG48845A1/en unknown
- 1993-09-22 DK DK93920624.9T patent/DK0661981T3/da active
- 1993-09-22 SK SK368-95A patent/SK36895A3/sk unknown
- 1993-09-22 AT AT93920624T patent/ATE141054T1/de active
- 1993-09-22 MD MD96-0294A patent/MD960294A/ro not_active Application Discontinuation
- 1993-09-23 IL IL107087A patent/IL107087A0/xx not_active IP Right Cessation
- 1993-09-24 MX MX9305887A patent/MX9305887A/es unknown
- 1993-09-24 CN CN93119844A patent/CN1057908C/zh not_active Expired - Fee Related
- 1993-09-24 ZA ZA937068A patent/ZA937068B/xx unknown
1995
- 1995-03-23 NO NO951122A patent/NO309457B1/no not_active IP Right Cessation
- 1995-06-13 IN IN670CA1995 patent/IN181289B/en unknown
- 1995-06-30 HU HU95P/P00651P patent/HU211698A9/hu unknown
1996
- 1996-09-26 GR GR960402522T patent/GR3021171T3/el unknown
1997
- 1997-03-20 HK HK35397A patent/HK35397A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
AP9300568A0 (en)	1993-10-31
DE69303931T2 (de)	1997-01-09
MD960294A (ro)	1997-10-31
EP0661981A1 (en)	1995-07-12
ES2091031T3 (es)	1996-10-16
DE69303931D1 (de)	1996-09-12
ATE141054T1 (de)	1996-08-15
CA2079205C (en)	1998-02-10
CA2079205A1 (en)	1994-03-26
CN1057908C (zh)	2000-11-01
ZA937068B (en)	1994-04-18
CZ288986B6 (cs)	2001-10-17
CN1092654A (zh)	1994-09-28
BR9307221A (pt)	1999-07-27
TW271401B (no)	1996-03-01
SK36895A3 (en)	1997-03-05
NZ255978A (en)	1997-02-24
HUT73637A (en)	1996-08-28
AU4812693A (en)	1994-04-26
IL107087A0 (en)	1993-12-28
DK0661981T3 (da)	1996-12-23
HK35397A (en)	1997-03-27
JPH08506797A (ja)	1996-07-23
SG48845A1 (en)	1998-05-18
JP3742955B2 (ja)	2006-02-08
HU227067B1 (en)	2010-06-28
HU9500857D0 (en)	1995-05-29
IN181289B (no)	1998-05-02
EP0661981B1 (en)	1996-08-07
NO309457B1 (no)	2001-02-05
MX9305887A (es)	1994-05-31
GR3021171T3 (en)	1996-12-31
PL308201A1 (en)	1995-07-24
AU670117B2 (en)	1996-07-04
NO951122L (no)	1995-03-23
CZ66295A3 (en)	1996-02-14
HU211698A9 (en)	1995-12-28
AP448A (en)	1996-01-18

Legal Events

Date	Code	Title	Description
2013-10-07	MK1K	Patent expired

Publication	Publication Date	Title
ES2138622T3 (es)	2000-01-16	Derivados de mercaptoacetilamido piridazo(1,2-a)(1,2)diazepina utilizados como inhibidores de encefalinasa y eca.
EP0677036A4 (en)	1996-01-10	PRODUCTION OF ODOR-FREE TETRAHYDROISOCUMULATES.
DE69329296D1 (de)	2000-09-28	Pyrazolopyrimidine als crf antagonisten
FI932169A0 (fi)	1993-05-13	Applikator foer infoerande av kraemliknande substans i en kvinnas vagina
MY111201A (en)	1999-09-30	New imidazopyridines
FI942166L (fi)	1994-07-08	Menetelmiä restenoosin ehkäisemiseksi
KR950700323A (ko)	1995-01-16	엔케팔리나제 및 안지오텐신 전환 효소의 억제제로서 유용한 아미노아세틸머캅토아세틸아미드 유도체(Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ACE)
NO940009L (no)	1994-01-09	Pyrazolopyrimidin og pyrimidinylbisfosfonsyreestere som anti-inflammatoriske midler
NO995245L (no)	1999-12-27	Anvendelse av tetrahydropyridinderivater for fremstilling av medisiner for å behandle sykdommer som bevirker demyelinisering
ES2157992T3 (es)	2001-09-01	Alcoxi-alquil-carbamatos de imidazo(1,2-a)piridinas.
DK0869965T3 (da)	2000-10-16	Steroidnitritesterderivater anvendelige som antiinflammatoriske lægemidler
AU6422294A (en)	1995-10-17	Use of hyaluronic acid and forms to prevent arterial restenosis
DE69611452D1 (de)	2001-02-08	Benzothiophenderivate
HU9500857D0 (en)	1995-05-29	Use of hyaluronic acid and forms to prevent arterial restenosis
GR3030566T3 (en)	1999-10-29	Nipecotic acid derivatives as antithrombic compounds
FI935168A7 (fi)	1994-05-24	4-kloori-2-tiofeenikarboksyylihapon regioselektiivinen synteesi
FI951377L (fi)	1995-03-23	N-asetyylineuramiinihappojohdannaisten synteesi
FI951378L (fi)	1995-03-23	N-asetyyli-neuramiinihapon johdannaisten synteesi
FI953106A7 (fi)	1995-07-13	Difuoripentapeptidijohdannaiset anti-inflammatorisina aineina
FI954422A0 (fi)	1995-09-19	Ferroseenin käyttö
FI933300L (fi)	1994-01-24	Foerfarande foer rengoering av klorvaetesyra i gasform
UY24327A1 (es)	2000-12-29	Derivados de cefalosporina
HUP9902417A2 (hu)	1999-11-29	Alfa-ketoészterek, és alfa-ketoamidok acilezett enol-származékai
AP9400608A0 (en)	1995-07-12	"New nicotinic acid derivative".
ITMI920873A0 (it)	1992-04-10	Composizioni farmaceutiche rettali per il trattamento dell'ipertrofia prostatica